The Federal Trade Commission has accused three major pharmacy benefit managers of inflating insulin prices, the agency said ...

The FTC says insulin prices started increasing in 2012, coinciding with PBMs creating “exclusionary” drug formularies.

The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the ...

The Federal Trade Commission has brought an administrative complaint against three of the country's largest pharmacy benefit ...

Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

The complaint targets the group purchasing organizations affiliated with the "big three" pharmacy benefit managers: CVS ...

The Federal Trade Commission's administrative complaint follows an interim report from the agency regarding PBM practices.

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

The FTC said CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx profit at the expense of patients forced to ...

FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices – Includes Caremark, Express Scripts, ...